Low-Dose Aspirin and Hepatic Fat Quantity in Patients With MASLD
- PMID: 39023883
- DOI: 10.1001/jama.2024.11617
Low-Dose Aspirin and Hepatic Fat Quantity in Patients With MASLD
Comment on
-
Aspirin for Metabolic Dysfunction-Associated Steatotic Liver Disease Without Cirrhosis: A Randomized Clinical Trial.JAMA. 2024 Mar 19;331(11):920-929. doi: 10.1001/jama.2024.1215. JAMA. 2024. PMID: 38502074 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
